Wave Life Sciences Ltd.
WVE
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company aā¦ read more
Healthcare
Biotechnology
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$15.98
Price+2.83%
$0.44
1Y
Price
Market Cap
$2.621b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-581.2%
EBITDA Margin-580.2%
Net Profit Margin-532.4%
Free Cash Flow MarginRevenue
$109.230m
-13.3%
1y CAGR+995.8%
3y CAGR+724.1%
5y CAGREarnings
-$121.946m
-33.9%
1y CAGR-12.7%
3y CAGR-17.6%
5y CAGREPS
-$0.75
-28.6%
1y CAGR+5.2%
3y CAGR+7.2%
5y CAGRBook Value
$124.549m
$241.378m
Assets$116.829m
Liabilities$19.772m
DebtDebt to Assets
8.2%
-0.2x
Debt to EBITDAFree Cash Flow
-$198.170m
-31.7%
1y CAGR-195.7%
3y CAGR-157.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company